Karachi: The Searle Company Limited has announced a meeting of its Board of Directors scheduled for April 30, 2025, to take place in Karachi and via video conferencing. The primary agenda for the meeting includes the review and approval of the unaudited condensed interim financial statements for the quarter ending March 31, 2025, as well as the declaration of any entitlements.

In compliance with clause 5.6.4 of the Rule Book of the Pakistan Stock Exchange (PSX), the company has declared a "Closed Period" from April 24, 2025, to April 30, 2025. During this period, no dealings in the company’s shares by any Director, CEO, or Executive, whether directly or indirectly, will be permitted.

According to information available from the Pakistan Stock Exchange (PSX), the declaration of the Closed Period ensures that no insider trading occurs before the financial results are publicly disclosed. This measure is intended to maintain transparency and fairness in the market, as the company prepares to disclose its financial performance for the quarter.

The company has also communicated this information to the TRE Certificate holders of the exchange, ensuring that all relevant stakeholders are informed of the upcoming board meeting and the associated Closed Period. The Searle Company Limited operates within the designated market category of pharmaceutical and healthcare products.